6.5 Intravenous Therapy, Fluid/Electrolyte Balance & Blood Transfusion Safety

Intravenous Therapy, Fluid/Electrolyte Balance & Blood Transfusion Safety

Clinical Core: Intravenous infusion therapy, electrolyte homeostasis, and hemotherapy are life-preserving clinical interventions that carry high liability and severe physiological hazards. Administering an inappropriate intravenous crystalloid can precipitate fatal cerebral herniation or pulmonary edema, while failing to detect an extravasation or mismanaging a transfusion reaction can cause permanent limb ischemia or acute hemolytic death. Registered nurses must maintain uncompromising vigilance across vascular access assessment, fluid tonicity dynamics, and blood safety protocols.

Intravenous Fluids: Tonicity, Osmolality and Fluid Shifts

Body fluids are distributed across two primary compartments: the Intracellular Fluid (ICF), accounting for approximately two-thirds of total body water, and the Extracellular Fluid (ECF), comprising the intravascular plasma and interstitial fluid. Fluid movement between compartments is governed by osmosis, driven by the concentration of osmotically active solutes.

• Normal Serum Osmolality: The physiological benchmark of human plasma is 275 to 295 mOsm/kg. Intravenous crystalloid solutions are classified relative to this baseline.

1. Isotonic Solutions (Approximately 275 to 295 mOsm/L)

Isotonic crystalloids possess an effective osmolality approximately equal to human plasma. When infused into the vascular compartment, they produce no net osmotic gradient across cellular membranes, remaining primarily within the extracellular fluid space.

• 0.9% Sodium Chloride (Normal Saline / NS, 308 mOsm/L): Contains $154\ \text{mEq/L}$ of sodium and $154\ \text{mEq/L}$ of chloride. It is the fluid of choice for initial resuscitation in hypovolemic shock, severe dehydration, diabetic ketoacidosis resuscitation, and metabolic alkalosis. Normal Saline is the ONLY crystalloid solution compatible with packed red blood cells. Excessive infusions can cause hyperchloremic metabolic acidosis.
• Lactated Ringer's (LR / Hartmann's Solution, 273 mOsm/L): An isotonic, balanced electrolyte solution containing sodium ($130\ \text{mEq/L}$), chloride ($109\ \text{mEq/L}$), potassium ($4\ \text{mEq/L}$), calcium ($2.7\ \text{mEq/L}$), and sodium lactate ($28\ \text{mEq/L}$). The liver metabolizes lactate into bicarbonate, providing a physiological buffering mechanism. LR is the fluid of choice for acute fluid resuscitation in burn trauma, acute surgical hemorrhage, and hypovolemia. Contraindications: Avoid LR in severe hepatic failure (inability to metabolize lactate causes lactic acid accumulation) and severe hyperkalemia.
• 5% Dextrose in Water (D5W, 252 mOsm/L in container): D5W is isotonic in the intravenous bag. However, once infused into the bloodstream, glucose is rapidly taken up and metabolized by cells via insulin. This leaves behind hypotonic free water, which disperses throughout both the ECF and ICF compartments. Consequently, D5W acts physiologically as a hypotonic fluid in vivo. Avoid D5W in clients with elevated intracranial pressure or hypovolemic shock.

2. Hypotonic Solutions (Less than 270 mOsm/L)

Hypotonic crystalloids possess an effective solute concentration lower than plasma (less than $270\ \text{mOsm/L}$). Infusing a hypotonic fluid lowers intravascular osmolality, creating an osmotic gradient that drives water out of the vascular space and into the intracellular compartment, causing cells to swell.

• Common Solutions: 0.45% Sodium Chloride (half-normal saline, $154\ \text{mOsm/L}$), 0.33% NaCl, 0.225% NaCl, 2.5% Dextrose in Water (D2.5W).
• Clinical Indications: Hypertonic intracellular dehydration (e.g., severe hypernatremia, maintenance fluid in diabetic ketoacidosis following initial volume resuscitation with normal saline).
• Contraindications & Hazards: Never administer hypotonic solutions to clients with traumatic brain injury, acute stroke, or suspected intracranial hypertension. The osmotic shift of water into cerebral brain cells produces severe cerebral edema and fatal uncal herniation. Hypotonic fluids are also contraindicated in acute hypovolemic shock, as they deplete intravascular volume.

3. Hypertonic Solutions (Greater than 300 mOsm/L)

Hypertonic solutions possess an osmolality significantly higher than human plasma (greater than $300\ \text{mOsm/L}$). When infused into the bloodstream, they elevate intravascular osmolality, pulling water out of the intracellular compartment and into the vascular space via osmosis, causing cells to shrink.

• Common Solutions: 3% Sodium Chloride ($1,026\ \text{mOsm/L}$), 5% Sodium Chloride, 10% Dextrose in Water (D10W, $505\ \text{mOsm/L}$), 50% Dextrose in Water (D50W), 5% Dextrose in 0.9% Normal Saline (D5NS), 5% Dextrose in Lactated Ringer's (D5LR).
• Clinical Indications: Emergent treatment of severe, symptomatic, life-threatening hyponatremia accompanied by seizures, coma, or status epilepticus; and acute management of elevated intracranial pressure and cerebral edema.
• Safety Precautions: Highly hypertonic solutions (such as 3% NaCl) must be infused via central venous catheters or large-bore peripheral lines using electronic volumetric pumps in intensive care environments. Continuous neurological monitoring and frequent lung auscultation are mandatory to detect acute circulatory overload. Rapid overcorrection of chronic hyponatremia (greater than $8\ \text{to}\ 10\ \text{mEq/L}$ in 24 hours) causes Central Pontine Myelinolysis (Osmotic Demyelination Syndrome), producing irreversible flaccid quadriplegia, dysarthria, and locked-in syndrome.

---

Intravenous Complications: Assessment and Management

Nurses must continuously inspect peripheral and central intravenous access sites to identify complications early.

---

Fluid and Electrolyte Imbalances: Emergency Resuscitation

1. Sodium Imbalances (Normal: 135 to 145 mEq/L)

• Hyponatremia (less than 135 mEq/L): Hypoosmolality causes cellular swelling. Neurological symptoms dominate due to cerebral edema: headache, confusion, lethargy, muscle twitching, seizures, coma. Treatment depends on etiology: fluid restriction for euvolemic/dilutional hyponatremia; 0.9% Normal Saline for hypovolemic hyponatremia; and cautious infusion of 3% hypertonic saline for acute symptomatic seizures.
• Hypernatremia (greater than 145 mEq/L): Hyperosmolality causes cellular dehydration. S/S: Intense thirst, dry sticky mucous membranes, flushed skin, hyperreflexia, agitation, lethargy. Treatment: Slow rehydration with hypotonic solutions (0.45% NaCl or D5W) to avoid precipitating cerebral edema.

2. Potassium Imbalances (Normal: 3.5 to 5.0 mEq/L)

Potassium is the primary intracellular cation, regulating cardiac rhythmicity, neuromuscular transmission, and acid-base balance.

• Hypokalemia (less than 3.5 mEq/L): Causes include loop diuretics (furosemide), gastrointestinal losses (vomiting, diarrhea, NG suction), and hyperaldosteronism. S/S: Muscle weakness, hyporeflexia, leg cramps, paralytic ileus, paresthesias. ECG Manifestations: Flattened or inverted T waves, ST segment depression, and prominent U waves. Treatment: Oral potassium replacement; or IV potassium chloride infused at rate not exceeding 10 to 20 mEq/hr (never IV push!).
• Hyperkalemia (greater than 5.0 mEq/L): Causes include acute kidney injury, chronic renal failure, potassium-sparing diuretics (spironolactone), ACE inhibitors, massive crush injuries, burns, and acidosis. S/S: Muscle twitches, paresthesias, ascending flaccid paralysis, life-threatening cardiac arrhythmias. ECG Manifestations: Tall, peaked T waves (early sign), prolonged PR interval, widening of the QRS complex, loss of P waves, progressing to a fatal "sine wave" pattern and ventricular fibrillation/asystole.

The Hyperkalemia Emergency Resuscitation Protocol

When hyperkalemia produces ECG abnormalities, the nurse executes a structured 5-step pharmacological intervention:

1. Myocardial Membrane Stabilization (Immediate): Administer Intravenous Calcium Gluconate (10%) $10\ \text{mL}$ IV over 2 to 3 minutes (or calcium chloride via central access). Calcium directly antagonizes the cardiotoxic membrane effects of hyperkalemia, restoring myocardial excitability within 1 to 3 minutes. Crucial clinical note: Calcium does NOT lower serum potassium levels; it shields the heart from lethal arrhythmias for 30 to 60 minutes while potassium-lowering therapies are initiated.
2. Intracellular Shift via Insulin and Glucose: Administer 10 units of Regular Insulin IV push combined simultaneously with 50 mL of 50% Dextrose (D50W, 25 g). Insulin stimulates the sodium-potassium ATPase pump, rapidly driving potassium from extracellular fluid into cells, lowering serum potassium within 15 to 30 minutes. Dextrose prevents severe insulin-induced hypoglycemia.
3. Intracellular Shift via Beta-2 Agonists: Administer high-dose nebulized Albuterol ($10\ \text{to}\ 20\ \text{mg}$) over 15 minutes. Beta-2 adrenergic stimulation activates the sodium-potassium pump to promote further intracellular potassium uptake.
4. Intracellular Shift via Alkalinization: Administer Intravenous Sodium Bicarbonate ($50\ \text{mEq}$) if hyperkalemia is accompanied by concurrent metabolic acidosis.
5. Potassium Elimination from the Body: The preceding interventions temporarily redistribute potassium. Permanent elimination requires: loop diuretics (furosemide) in clients with intact renal function; gastrointestinal cation exchangers (sodium zirconium cyclosilicate [$Lokelma$], patiromer, or sodium polystyrene sulfonate [$Kayexalate$]); or emergent Hemodialysis (the definitive treatment in end-stage renal disease).

---

Blood Transfusion Safety, Protocols & Reaction Management

Administering packed red blood cells (PRBCs), platelets, or fresh frozen plasma requires meticulous adherence to transfusion safety protocols.

Pre-Transfusion Verification

1. Prescription and Informed Consent: Confirm valid medical provider prescription and documented, signed client informed consent.
2. Type and Crossmatch: Verify blood sample validity (typically drawn within 72 hours of transfusion).
3. Dual-Nurse Independent Verification: At the client's bedside, two registered nurses (or licensed practitioners) independently cross-reference the client's identity and blood product documentation:
   • Client's full legal name and hospital identification number on wristband.
   • Donor blood unit identification number on unit label and blood bank form.
   • ABO blood group and Rh factor compatibility.
   • Expiration date and time of the blood product.
   • Visual inspection of blood unit: inspect for clots, clumping, discoloration, purple hues, gas bubbles, or container leaks. If any abnormality exists, return unit to blood bank immediately.

Administration Standards

• Vascular Access: Large-bore peripheral intravenous access is required: 18-gauge or 20-gauge cannula to prevent mechanical hemolysis of fragile erythrocytes (a 22-gauge may be utilized in fragile geriatric or pediatric clients if flow rates are appropriately reduced).
• Dedicated Administration Tubing: Use a specialized blood administration Y-tubing set equipped with an in-line micro-aggregate blood filter (170 to 260 micrometers) to remove fibrin clots and cellular debris.
• Compatible Priming Solution: 0.9% Normal Saline is the ONLY solution compatible with blood components. Priming or flushing tubing with D5W causes immediate red cell hemolysis and clumping; priming with Lactated Ringer's introduces calcium, which overcomes the citrate anticoagulant in the blood bag (citrate works by binding calcium), so clots can form in the tubing.
• Timing and Baseline Vitals: Obtain baseline vital signs within 30 minutes prior to initiation. Retrieve blood from the blood bank only when ready to infuse; transfusion must commence within 30 minutes of leaving blood bank storage.
• The Critical First 15 Minutes: Initiate the transfusion at a slow rate: less than 2 mL/min (approximately 25 to 50 mL total over the first 15 minutes). The registered nurse must remain at the bedside for the entire first 15 minutes, as catastrophic hemolytic and anaphylactic reactions typically manifest within this initial volume.
• Transfusion Duration: Reassess vital signs at 15 minutes. If no signs of reaction appear, increase infusion to the prescribed rate. A unit of PRBCs must be completely infused within 4 hours of removal from the blood bank. Blood hanging beyond 4 hours must be stopped and discarded due to exponential bacterial proliferation risks.

Classification of Transfusion Reactions

• Acute Hemolytic Reaction: Caused by ABO/Rh incompatibility; recipient antibodies trigger complement-mediated intravascular hemolysis. S/S: Immediate onset, fever, chills, flank/lower back pain (hemoglobin clearance through renal tubules), tachycardia, hypotension, dyspnea, hemoglobinuria, DIC, acute renal failure, and shock.
• Febrile Non-Hemolytic Reaction: Caused by recipient antibodies reacting against donor white blood cells or accumulating cytokines. Most common reaction. S/S: Temperature elevation 1 degree Celsius (1.8 degrees Fahrenheit) or greater above baseline, chills, rigors, headache, flushing, anxiety. Prevented by using leukocyte-reduced blood products.
• Allergic / Anaphylactic Reaction: Hypersensitivity to donor plasma proteins. Mild form causes pruritus, urticaria, and localized erythema (treated with antihistamines; transfusion may restart if no systemic signs). Severe anaphylaxis (frequently in IgA-deficient clients receiving IgA-positive blood) causes sudden stridor, wheezing, bronchospasm, laryngeal edema, hypotension, and shock.
• Transfusion-Related Acute Lung Injury (TRALI): Donor anti-HLA or anti-neutrophil antibodies activate neutrophils in recipient pulmonary microvasculature, causing acute pulmonary capillary permeability. Leading cause of transfusion-related mortality. S/S: Acute non-cardiogenic pulmonary edema, severe dyspnea, hypoxemia, fever, and bilateral diffuse infiltrates on chest X-ray within 6 hours of transfusion without volume overload.
• Transfusion-Associated Circulatory Overload (TACO): Hypervolemia occurring when blood is infused faster than the circulatory system can accommodate. S/S: Hypertension, jugular venous distention, bounding pulse, bibasilar pulmonary crackles, tachypnea, orthopnea, elevated BNP. Managed with high Fowler's positioning, supplemental oxygen, and intravenous furosemide.

Emergency Transfusion Reaction Protocol

If a transfusion reaction is suspected at any point, the nurse must execute the following protocol immediately:

1. STOP THE TRANSFUSION IMMEDIATELY. This is the first and most critical action to limit infused antigen volume.
2. Disconnect the blood tubing set from the client's IV cannula. Never flush the blood remaining in the administration tubing into the client.
3. Maintain vascular access: Connect a new, clean IV administration set primed with 0.9% Normal Saline directly to the IV cannula, infusing at a slow maintain-vein-open (KVO) rate.
4. Assess client vital signs, airway, breathing, and circulation; administer supplemental oxygen and emergency medications (epinephrine, antihistamines, fluids) as indicated.
5. Notify the medical provider and hospital blood bank immediately.
6. Return the blood bag, remaining tubing, filter, and labels to the blood bank in a biohazard container for comprehensive serological and microbial investigation.
7. Collect post-reaction blood and urine specimens (for direct antiglobulin Coombs testing, serum bilirubin, free plasma hemoglobin, and urinalysis for hemoglobinuria) per institutional protocol.
8. Document meticulously: Record time of reaction onset, total volume infused, specific clinical manifestations, vital sign trends, nursing interventions, provider communications, and client response.